MyAverix Finance
CO · Healthcare
Zealand Pharma A/S (ZEAL)
Biotechnology
Zealand Pharma A/S (ZEAL) is listed on CO in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $22.41B, P/E ratio is 3.56, net margin is 69.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ZEAL
Zealand Pharma A/S (ZEAL) — FAQ
What is Zealand Pharma A/S's market cap?
Zealand Pharma A/S (ZEAL) has a reported market cap of $22.41B (data as of 2026-05-24).
What is ZEAL's P/E ratio?
The price-to-earnings (P/E) ratio for Zealand Pharma A/S (ZEAL) is 3.56 (data as of 2026-05-24).
Does Zealand Pharma A/S pay a dividend?
Dividend yield is not available in the current snapshot for Zealand Pharma A/S (ZEAL). Check the MyAverix Finance app for the latest dividend data.
What sector is Zealand Pharma A/S in?
Zealand Pharma A/S (ZEAL) is classified in the Healthcare sector (Biotechnology industry).
What exchange is ZEAL listed on?
ZEAL is listed on CO.
What is Zealand Pharma A/S's net margin?
Zealand Pharma A/S (ZEAL) reports a net margin of 69.2% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.